Skip to content

E2007

DRUG14 trials

Sponsors

Eisai Inc., Eisai Limited, Eisai Co., Ltd.

Conditions

EpilepsyHealthy SubjectsMigraine ProphylaxisNeuralgiaParkinson's DiseasePartial Onset SeizuresRefractory Partial Seizures

Phase 1

Phase 2

Efficacy and Safety Study of E2007 in Migraine Prophylaxis
CompletedNCT00154063
Eisai Inc.Migraine Prophylaxis
Start: 2005-01-31End: 2006-06-30Updated: 2015-06-08
A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations
CompletedNCT00165789
Eisai Inc.Parkinson's Disease
Start: 2005-09-30End: 2006-09-30Updated: 2015-06-02
Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures
CompletedNCT00416195
Eisai Co., Ltd.Epilepsy
Start: 2006-12-31End: 2008-03-31Updated: 2014-07-11
A Study of E2007 In Patients With Parkinson's Disease
TerminatedNCT00427011
Eisai Inc.Parkinson's Disease
Start: 2007-02-28End: 2008-04-30Updated: 2013-02-11
The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations
WithdrawnNCT00451633
Eisai Inc.Parkinson's Disease
Start: 2007-03-31Updated: 2013-10-31
Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)
CompletedNCT00592904
Eisai Inc.Neuralgia
Start: 2008-01-31End: 2011-07-31Updated: 2016-01-21
An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)
CompletedNCT00849212
Eisai Co., Ltd.Refractory Partial Seizures
Start: 2009-04-30End: 2009-11-30Updated: 2013-02-07
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With Wearing Off Motor Fluctuations and On Period Dyskinesias
CompletedNCT01172379
Eisai LimitedParkinson's Disease
Start: 2004-05-31Target: 2Updated: 2014-08-22
Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy
CompletedNCT03780907
Eisai Co., Ltd.Epilepsy
Start: 2003-02-14End: 2003-08-06Updated: 2018-12-19

Phase 3

Related Papers